Author:
Zintgraff Jonathan,Gagetti Paula,Napoli Daniela,Sanchez Eluchans Nahuel,Irazu Lucia,Moscoloni Maria,Regueira Mabel,Lara Claudia S.,Corso Alejandra
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference56 articles.
1. Prevention of invasive pneumococcal disease: problems emerged after some years of the 13-valent pneumococcal conjugate vaccine use;Principi;Curr Infect Dis Rep,2018
2. A visual review of the human pathogen S. pneumoniae;Engholm;FEMS Microbiol Rev,2017
3. A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral streptococcus;Ganaie;mBio,2020
4. Merck Sharp & Dohme Corp. Merck Submits Applications for Licensure of V114, the Company’s Investigational 15-valent Pneumococcal Conjugate Vaccine, for Use in Adults to the U.S. FDA and European Medicines Agency. Merck.com; 2020.
5. Pfizer A Phase 3, Randomized, Open-label Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine in Adults 65 Years of Age and Older with Prior Pneumococcal Vaccination; clinicaltrials.gov; 2020.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献